Bone Mineral Density in Spinal Fusion of Rabbit Bone Marrow Mesenchymal Stem Cells

2014 ◽  
Vol 17 (3) ◽  
pp. 406
Author(s):  
T.-H. Lee ◽  
Y.-H. Huang ◽  
A.-L. Kwan ◽  
W.-C. Lin ◽  
T.-C. Lee
2020 ◽  
Vol 10 (3) ◽  
pp. 418-423
Author(s):  
Shengxing Liu ◽  
Kaizhong Zhu ◽  
Hao Qi ◽  
Hai Zhao ◽  
Dingzhong Chen

The current treatment for osteoporosis cannot restore the lost bone mass. Exosomes can not only delay bone loss, but also promote osteogenic proliferation and differentiation. This study aims to determine whether BMSCs-derived exosomes could improve osteoporosis in rats. A rat model of osteoporosis was established by excising bilateral ovaries. Whole bone marrow cell inoculation method and adherent purification were used to culture rat bone marrow mesenchymal stem cells (BMSCs). Osteoporosis rats were treated with BMSCs-derived exosomes followed by analysis of serum osteocalcin level by ELISA and bone mineral density and volume fraction by Micro-CT. Osteoblasts were treated with exosomes followed by analysis of cell proliferation by CCK-8 assay and expression of key molecules in the apoptotic signaling by real-time PCR and Western blot. Serum osteocalcin, bone mineral density and volume fraction in OVX group were significantly lower than those in control group and Exo group (P < 0.05) with significant differences between Exo group and CON group. With the increase of exosome concentration, the survival rate of osteoblasts was increased gradually. Cleaved Caspase-3 expression was reduced and Bcl-2 level was elevated gradually. BMSCs-derived exosomes can promote osteoblast proliferation by inhibiting apoptotic signaling pathway and improving osteoporosis.


2020 ◽  
Vol 10 (12) ◽  
pp. 1865-1870
Author(s):  
Yang Ying ◽  
Binghao Zhao ◽  
Wei Qian ◽  
Li Xu

Bone marrow mesenchymal stem cells (BMSCs) have self-renewal potential with multi-directional differentiation. Progranulin prevents bone degradation, inhibits inflammation and protects bone tissue. However, the role of Progranulin in osteoporotic BMSCs is unclear. Osteoporosis (OP) rat models were prepared by ovarian removal and treated with different doses (5 and 10 μM) of Progranulin followed by analysis of BMP-2 level by ELISA, bone mineral density and ALP activity. OP rat BMSCs were isolated and assigned into control group and Progranulin group followed by analysis of Progranulin level by ELISA, cell proliferation by MTT assay, RUNX2 and COL1A1 mRNA level by Real time PCR, and PI3K/Akt/PPARγ signaling protein level by Western blot. Progranulin treatment of OP rats dose-dependently increased BMP-2 expression, bone density and ALP activity. Compared with OP group, there were significant differences (P <0.05). Progranulin expression and BMSCs proliferation was increased, and RUNX2 and COL1A1 mRNA expression was elevated in Progranulin-treated OP group along with increased PI3K/Akt expression and decreased PPARγ protein expression. Compared with OP group, the difference was statistically significant, and the change was more significant with increasing concentration (P <0.05). Progranulin promotes BMSCs osteogenic differentiation and proliferation by regulating PI3K/Akt/PPARγ signaling pathway, which is beneficial for OP rats’ bone synthesis.


2008 ◽  
Vol 1 (1) ◽  
pp. 53 ◽  
Author(s):  
Simone Lapi ◽  
Francesca Nocchi ◽  
Roberta Lamanna ◽  
Simona Passeri ◽  
Mariacarla Iorio ◽  
...  

PeerJ ◽  
2018 ◽  
Vol 6 ◽  
pp. e4656 ◽  
Author(s):  
Marcello de Alencar Silva ◽  
Yulla Klinger de Carvalho Leite ◽  
Camila Ernanda Sousa de Carvalho ◽  
Matheus Levi Tajra Feitosa ◽  
Michel Muálem de Moraes Alves ◽  
...  

Background Tissue engineering has been shown to exhibit great potential for the creation of biomaterials capable of developing into functional tissues. Cellular expansion and integration depends on the quality and surface-determinant factors of the scaffold, which are required for successful biological implants. The objective of this research was to characterize and evaluate the in vitro characteristics of rabbit bone marrow mesenchymal stem cells (BM-MSCs) associated with a bacterial cellulose membrane (BCM). We assessed the adhesion, expansion, and integration of the biomaterial as well as its ability to induce macrophage activation. Finally, we evaluated the cytotoxicity and toxicity of the BCM. Methods Samples of rabbit bone marrow were collected. Mesenchymal stem cells were isolated from medullary aspirates to establish fibroblast colony-forming unit assay. Osteogenic, chondrogenic, and adipogenic differentiation was performed. Integration with the BCM was assessed by scanning electron microscopy at 1, 7, and 14 days. Cytotoxicity was assessed via the production of nitric oxide, and BCM toxicity was assessed with the MTT assay; phagocytic activity was also determined. Results The fibroblastoid colony-forming unit (CFU-F) assay showed cells with a fibroblastoid morphology organized into colonies, and distributed across the culture area surface. In the growth curve, two distinct phases, lag and log phase, were observed at 15 days. Multipotentiality of the cells was evident after induction of osteogenic, chondrogenic, and adipogenic lineages. Regarding the BM-MSCs’ bioelectrical integration with the BCM, BM-MSCs were anchored in the BCM in the first 24 h. On day 7 of culture, the cytoplasm was scattered, and on day 14, the cells were fully integrated with the biomaterial. We also observed significant macrophage activation; analysis of the MTT assay and the concentration of nitric oxide revealed no cytotoxicity of the biomaterial. Conclusion The BCM allowed the expansion and biointegration of bone marrow progenitor cells with a stable cytotoxic profile, thus presenting itself as a biomaterial with potential for tissue engineering.


Polymer Korea ◽  
2016 ◽  
Vol 40 (6) ◽  
pp. 915 ◽  
Author(s):  
Bo Ra Sim ◽  
Hye Min Kim ◽  
Soo Min Kim ◽  
Do Kyung Kim ◽  
Jeong Eun Song ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-13 ◽  
Author(s):  
Jun Li ◽  
Zeyu Huang ◽  
Bohua Li ◽  
Zhengdong Zhang ◽  
Lei Liu

Reconstruction of segmental bone defects poses a tremendous challenge for both orthopedic clinicians and scientists, since bone rehabilitation is requisite substantially and may be beyond the capacity of self-healing. Bone marrow mesenchymal stem cells (BMSCs) have been identified as an optimal progenitor cell source to facilitate bone repair since they have a higher ability for proliferation and are more easily accessible than mature osteoblastic cells. In spite of the potential of BMSCs in regeneration medicine, particularly for bone reconstruction, noteworthy limitations still remain in previous application of BMSCs, including the amount of cells that could be recruited, the compromised bone migration of grafted cells, reduced proliferation and osteoblastic differentiation ability, and likely tumorigenesis. Our current work demonstrates that BMSCs transplanted through the caudal vein can be mobilized by erythropoietin (EPO) to the bone defect area and participate in regeneration of new bone. Based on the histological analysis and micro-CT findings of this study, EPO can dramatically promote the effects on the osteogenesis and angiogenesis efficiency of BMSCs in vivo. Animals that underwent EPO+BMSC administration demonstrated a remarkable increase in new bone formation, tissue structure organization, new vessel density, callus formation, and bone mineral density (BMD) compared with the BMSCs alone and control groups. At the biomechanical level, we demonstrated that combing transplantation of EPO and BMSCs enhances bone defect reconstruction by increasing the strength of the diaphysis, making it less fragile. Therefore, combination therapy using EPO infusion and BMSC transplantation may be a new therapeutic strategy for the reconstruction of segmental bone defect.


Heart ◽  
2010 ◽  
Vol 96 (Suppl 3) ◽  
pp. A55-A55
Author(s):  
L. Zhengzhang ◽  
C. Yingzhang ◽  
S. Zhe ◽  
X. Haoping ◽  
C. Shi

Sign in / Sign up

Export Citation Format

Share Document